Early RSV infection turns maternal allergy into a powerful driver of childhood asthma
View as a Web Page
News Medical
 
  Pulmonology Pulmonology logo  
  The latest pulmonology news from News Medical  
 Bacterial enzyme linked to heart complications in pneumoniaBacterial enzyme linked to heart complications in pneumonia
 
Pneumonia is a disease that burdens the healthcare system with more that 1.2 million emergency room visits each year and more than 41,000 adult deaths in the United States.
 
 
 Early RSV infection turns maternal allergy into a powerful driver of childhood asthmaEarly RSV infection turns maternal allergy into a powerful driver of childhood asthma
 
Early-life RSV infection and parental allergy interact to substantially increase childhood asthma risk, supported by population data from more than 1.5 million children and mechanistic mouse experiments. The study shows that viral infection reprograms neonatal immune responses by altering how maternally transferred allergen-specific antibodies are handled, driving long-term allergic airway disease.
 
   Sweat testing could transform drug monitoring and diabetes careSweat testing could transform drug monitoring and diabetes care
 
Innovative sweat sampling techniques could revolutionize diagnostics, offering insights into glucose levels and environmental toxins with minimal discomfort.
 
   Cystic fibrosis patients on triple-drug therapy can safely reduce daily lung treatmentsCystic fibrosis patients on triple-drug therapy can safely reduce daily lung treatments
 
A new multi-site study led by researchers at CU Anschutz shows that people with cystic fibrosis (CF) who start the triple-drug therapy elexacaftor/tezacaftor/ivacaftor (ETI) can safely reduce many of their daily lung treatments while maintaining good health for years.
 
   High BMI and poor physical fitness in adolescence linked to severe bacterial infections in adulthoodHigh BMI and poor physical fitness in adolescence linked to severe bacterial infections in adulthood
 
High BMI and poor physical fitness during later adolescence increase the risk of both contracting and dying from sepsis and other severe bacterial infections in adulthood, according to a study from the University of Gothenburg.
 
 Enterprise Therapeutics publishes results of Phase 1 study of ETD001, a novel inhaled ENaC blocker for treatment of Cystic Fibrosis, in The Journal of Cystic Fibrosis
 
Enterprise Therapeutics publishes results of Phase 1 study of ETD001, a novel inhaled ENaC blocker for treatment of Cystic Fibrosis, in The Journal of Cystic FibrosisEnterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of people with respiratory diseases, today announced the publication of a peer reviewed study in The Journal of Cystic Fibrsosis.
 
 
 Asthma treatment and long-term management across all age groups
 
Asthma treatment and long-term management across all age groupsThe revised asthma framework helps shape more consistent, effective treatment decisions in clinical practice.
 
 
 The growing importance of FeNO testing in asthma care
 
The growing importance of FeNO testing in asthma careFeNO testing is increasingly recognized as a key first step in asthma assessment under the updated UK guidelines.
 
 
 Clinical trial support across therapeutic areas
 
Clinical trial support across therapeutic areasAs a pinnacle of medical innovation, clinical trials are vital for developing groundbreaking treatments.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025